Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    LifeStance Health Group I...

    NASDAQ: LFST · Real-Time Price · USD
    5.40
    -0.04 (-0.74%)
    At close: Aug 18, 2025, 3:59 PM
    5.39
    -0.19%
    After-hours: Aug 18, 2025, 05:09 PM EDT
    -0.74%
    Bid 5.35
    Market Cap 2.1B
    Revenue (ttm) 1.32B
    Net Income (ttm) -24.81M
    EPS (ttm) -0.04
    PE Ratio (ttm) -135
    Forward PE 87.1
    Analyst Buy
    Ask 5.7
    Volume 1,404,762
    Avg. Volume (20D) 2,517,091
    Open 5.45
    Previous Close 5.44
    Day's Range 5.40 - 5.58
    52-Week Range 3.74 - 8.61
    Beta 1.13

    About LFST

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol LFST
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for LFST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    LifeStance Health Group Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    +13.21%
    LifeStance Health Group shares are trading higher ... Unlock content with Pro Subscription
    3 months ago
    -15.88%
    LFST stock has given up its prior gain. LifeStance Health Group shares were trading higher after the company reported better-than-expected Q1 sales results.
    news image

    1 week ago · seekingalpha.com

    LifeStance Health Group, Inc. (LFST) Q2 2025 Earnings Call Transcript

    LifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants David Patrick Bourdon - CEO & Director Monica Prokocki - Vice President of ...

    news image

    1 week ago · zacks.com

    LifeStance Health Group (LFST) Reports Q2 Loss, Tops Revenue Estimates

    LifeStance Health Group (LFST) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.06 per share a year ago.

    news image

    1 month ago · zacks.com

    Bet on 5 Top-Ranked Stocks With Rising P/E

    CSW, ASAN, and others show rising P/E trends -- suggesting breakout potential backed by strong earnings surprises.

    news image

    1 month ago · seekingalpha.com

    LifeStance: First Profit, Expanding Margins, And Hybrid Model Make It A Buy Despite Valuation Concerns

    LifeStance Health is showing a real turnaround, posting its first-ever net profit and rapidly expanding margins, signaling operational discipline and scalable growth. The company's hybrid care model p...

    news image

    1 month ago · zacks.com

    LifeStance Health (LFST) Upgraded to Strong Buy: What Does It Mean for the Stock?

    LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

    news image

    2 months ago · zacks.com

    After Plunging 9.9% in 4 Weeks, Here's Why the Trend Might Reverse for LifeStance Health (LFST)

    The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street a...

    news image

    2 months ago · zacks.com

    Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet

    The consensus price target hints at a 45% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings e...

    news image

    2 months ago · https://247wallst.com

    Live Nasdaq Composite: Market Optimism Returns Amid EU Tariff Delay

    Live Updates Live Coverage Has Ended Goldman Bullish on Nuclear Stocks 12:05 pm by Gerelyn Terzo Goldman Sachs is bullish on two nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR)...

    news image

    2 months ago · https://247wallst.com

    S&P 500 (NYSEARCA: SPY) Live: Markets Upbeat on EU Tariff Surprise and Resilient Economy

    Live Updates Live Coverage Has Ended Wall Street Endorses Nuclear Stocks 12:10 pm by Gerelyn Terzo Goldman Sachs has issued a bullish report on a pair of nuclear stocks – Cameco (NYSE: CCJ) and NuScal...

    Add to Watchlist